EAM
Eventide Asset Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4M | Buy |
921,639
+41,830
| +5% | +$1.52M | 0.59% | 60 |
|
|
2025
Q1 | $27.4M | Buy |
879,809
+56,419
| +7% | +$1.76M | 0.55% | 67 |
|
|
2024
Q4 | $21M | Buy |
823,390
+50,767
| +7% | +$1.29M | 0.38% | 87 |
|
|
2024
Q3 | $21.9M | Buy |
772,623
+22,993
| +3% | +$650K | 0.38% | 84 |
|
|
2024
Q2 | $19.8M | Buy |
749,630
+58,943
| +9% | +$1.55M | 0.34% | 92 |
|
|
2024
Q1 | $21M | Buy |
690,687
+156,712
| +29% | +$4.76M | 0.33% | 90 |
|
|
2023
Q4 | $15M | Sell |
533,975
-470,171
| -47% | -$13.2M | 0.24% | 104 |
|
|
2023
Q3 | $27.3M | Sell |
1,004,146
-35,572
| -3% | -$965K | 0.49% | 59 |
|
|
2023
Q2 | $32M | Sell |
1,039,718
-9,395
| -0.9% | -$289K | 0.54% | 58 |
|
|
2023
Q1 | $37.8M | Buy |
1,049,113
+300,690
| +40% | +$10.8M | 0.69% | 51 |
|
|
2022
Q4 | $29.6M | Buy |
+748,423
| New | +$29.6M | 0.58% | 56 |
|